Shay Capital LLC Viatris Inc Transaction History

Shay Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$8.77 - $10.85 $657,750 - $813,750	75,000 New	75,000 $812,000
Q3 2021 Nov 15, 2021	SELL	$13.25 - $15.13 $1.66 Million - $1.89 Million	-125,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$12.97 - $16.15 $1.22 Million - $1.52 Million	94,000 Added 303.23%	125,000 $1.79 Million
Q1 2021 Aug 13, 2021	SELL	$13.59 - $18.54 $4.97 Million - $6.78 Million	-365,550 Reduced 92.18%	31,000 $433,000
Q4 2020 Aug 13, 2021	BUY	$14.3 - $18.74 $5.67 Million - $7.43 Million	396,550 New	396,550 $7.43 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Shay Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Shay Capital LLC with notifications on news.